Sign in

You're signed outSign in or to get full access.

Joseph Geraci II

Chief Financial Officer at MCVT
Executive
Board

About Joseph Geraci II

Joseph A. Geraci II is Co‑Founder (2006), Director, and Chief Financial Officer of Mill City Ventures III, Ltd. (MCVT). He is 55 years old (as of FY 2024) and has served continuously as CFO and director since founding . Background includes managing Isles Capital, LLC (since 2002), and Mill City Advisors, LLC (since 2005), prior finance roles at Gelstat and Oak Ridge Financial Services . Notable risk factor: in August 2003, NASD barred Mr. Geraci from associating with any NASD member for violations of NASD Rule 2110 and SEC Rule 10b‑5 in 1999 .

Performance metrics such as TSR, revenue growth, and EBITDA growth tied to his compensation are not disclosed in the company’s filings reviewed .

Past Roles

OrganizationRoleYearsStrategic Impact
Mill City Ventures III, Ltd.Co‑Founder; Director & Chief Financial Officer2006–presentCo‑founded specialty finance company; ongoing CFO/director leadership
Gelstat CorporationDirector of FinanceJan–Aug 2005Finance leadership for consumer healthcare products firm
Oak Ridge Financial Services, Inc.Vice President (Broker-Dealer)2000–2004Structured and negotiated private debt/equity placements
Minneapolis brokerage firmsVarious roles1991–2000Built networks across sectors aiding investment sourcing

External Roles

OrganizationRoleYearsStrategic Impact
Isles Capital, LLCManaging Member2002–presentAdvisory/consulting to small businesses (public/private)
Mill City Advisors, LLCManaging Member2005–presentGeneral partner to investment LPs; direct investing mandate

Fixed Compensation

Metric2021202220232024
Base Salary ($)$150,000 $150,000 $200,000 $200,000
Cash Bonus ($)$100,000 $250,000 (incl. $200,000 declared, paid Jan 2023) $125,000 (declared, paid Jan 2024) $150,000 (declared, paid Jan 2025)
Stock Awards ($)$— $12,683 $— $—
Option Awards ($)$— $530,000 (grant date fair value; Nov 2022) $— $—
All Other Compensation ($)$41,197 $44,042 $45,014 $39,602
Total ($)$291,197 $986,725 $370,014 $389,602

Base salary agreements:

  • Effective Jan 1, 2023–Dec 31, 2024: $200,000 base salary; health insurance; 401(k) .
  • Effective Jan 1, 2025–Dec 31, 2026: $220,000 base salary; health insurance; 401(k) .
Base Salary Agreement202320242025
Contracted Base ($)$200,000 $200,000 $220,000

Performance Compensation

No formal annual incentive plan metrics (e.g., revenue, EBITDA, TSR, ESG) are disclosed; cash bonuses are determined by the Compensation Committee and paid after year‑end .

MetricWeightingTargetActualPayoutVesting
Annual Cash BonusNot disclosed Not disclosed Not disclosed $250,000 (2022), $125,000 (2023), $150,000 (2024) Paid Jan following year

Equity awards:

  • 250,000 non‑statutory stock options granted Nov 23, 2022, exercise price $2.12, ten‑year term, fully exercisable; shareholder approval Jan 20, 2023 .
  • Outstanding at Dec 31, 2023 and Dec 31, 2024: aggregate 500,000 NEO options (250,000 each to CEO and CFO) .
Option AwardsExercisable (#)Unexercisable (#)Exercise PriceExpiration
Geraci (Nov 23, 2022)250,000 0 $2.12 Nov 23, 2032

Equity Ownership & Alignment

Metric20202021
Direct & Indirect Shares702,500 held by Mr. Geraci; 17,273 by spouse; 290,055 via Lantern Advisers LLC co‑owned with Mr. Polinsky 1,008,828 shares beneficially owned; 9.35% of 10,790,413 shares outstanding as of Dec 31, 2021
% of Shares Outstanding9.35%
  • Vested vs unvested equity: Stock options fully exercisable (250,000); no unvested RSUs/PSUs disclosed .
  • Pledging/hedging: No company‑specific disclosures found in filings reviewed .
  • Ownership guidelines: Not disclosed for executives/directors in filings reviewed .

Employment Terms

Term2023–2024 Agreement2025–2026 Agreement
Effective DatesJan 1, 2023–Dec 31, 2024 Jan 1, 2025–Dec 31, 2026
Base Salary$200,000 $220,000
BenefitsCompany‑provided health insurance; 401(k) plan with matching up to 5% Health insurance; 401(k) plan
Non‑Compete / Non‑Solicit2 years; confidentiality covenants 2 years; confidentiality covenants
Termination (Cause / Death / Disability)Salary through date of termination Salary through date of termination
Termination (Other Non‑Cause)Base salary through remainder of term Base salary through remainder of term
Change‑of‑ControlNot specifically disclosed beyond above terms in filings reviewed

Board Governance

  • Board Service: Director since founding (2006), serving concurrently as CFO .
  • Independence: Executive director; independent director compensation table excludes Geraci (no director fees) .
  • Committees: Filings reviewed do not list Geraci on board committees; independent directors listed (Lyle Berman, Howard P. Liszt, Laurence S. Zipkin) .

Director compensation (2024):

DirectorCompensation ($)Bonus ($)Total ($)
Lyle Berman$40,000 $60,000 $100,000
Howard P. Liszt$40,000 $60,000 $100,000
Laurence S. Zipkin$40,000 $60,000 $100,000
Joseph A. Geraci II$0 $0 $0
Douglas M. Polinsky$0 $0 $0

Performance & Track Record

  • Internal control: Management disclosed a material weakness in internal control over financial reporting as of Dec 31, 2022; no auditor attestation required; signatures include CFO (Geraci) .
  • Strategic initiatives: Company announced a major strategic rebrand in Aug 2025 to SUI Group Holdings, reflecting a SUI blockchain treasury strategy; broader market developments during this period (post‑FY 2024) .
  • Equity capitalization events: Company disclosed 2022 NEO option grants and subsequent shareholder approval (Jan 20, 2023) .

Compensation Structure Analysis

  • Shift toward equity in 2022 via significant option grant ($530,000 fair value) vs prior years without options; but no RSUs/PSUs and no disclosed performance metrics for bonuses (suggests discretionary awards) .
  • Year‑over‑year cash mix: Cash base increased from $150,000 (2022) to $200,000 (2023–2024), then contracted base to $220,000 in 2025; cash bonuses remained material ($125k–$150k) .
  • Guaranteed pay vs at‑risk: Absence of disclosed performance targets for bonuses and lack of PSUs indicates lower formal pay‑for‑performance linkage vs market practice .
  • Equity awards: Options fully vested and long‑dated (2032), creating potential exercise optionality but limited retention tether without vesting gates .

Risk Indicators & Red Flags

  • Regulatory history: NASD bar (2003) is a governance risk consideration in capital markets and investor relations .
  • Internal control material weakness as of 2022 .
  • Dual role (CFO + Director) raises independence considerations; independent director fees exclude executives .

Investment Implications

  • Alignment: Significant historical share ownership (9.35% in 2021) and long‑dated fully vested options support skin‑in‑the‑game, but lack of disclosed performance metrics for annual bonuses and absence of PSUs/RSUs weakens formal pay‑for‑performance alignment .
  • Retention risk: Contractual severance (base salary through remainder of term) and 2‑year non‑compete/non‑solicit lower near‑term turnover risk; however, fully vested options reduce future equity vesting as a retention lever .
  • Trading signals: Fully exercisable options at $2.12 with 2032 expiry create optionality; monitor Form 4s around bonus payment dates and corporate events for potential selling pressure—no specific insider trade patterns were identified in filings reviewed .
  • Governance: Dual role CFO/director and prior NASD bar warrant continued oversight; independent directors receive cash retainers/bonuses, suggesting board relies on cash rather than equity, which may impact long‑term alignment .